Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
The new online Learning Center with new content can still be found under the “Training” folder on ...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...